Healthcare -
Medical - Diagnostics & Research - NASDAQ - US
$ 17.05
-11.4 %
$ 492 M
Market Cap
26.81
P/E
CSTL - REVENUE
Revenue CSTL - Castle Biosciences, Inc.
332 M
LAST VALUE
55.67%
2 YEAR CAGR
44.97%
5 YEAR CAGR
0.00%
10 YEAR CAGR